Table 4.
Malaria episodes | Person‐years | Incidence ratea | Hazard ratio (95% CI) | P‐value | Adjusted hazard ratio (95% CI) | P‐value | |
---|---|---|---|---|---|---|---|
SMC period | |||||||
All children | |||||||
AL group | 72 | 314.0 | 229.3 | [reference] | – | [reference] | – |
DP | 90 | 318.9 | 282.2 | 1.23 (0.87, 1.73) | 0.234 | 1.18 (0.83, 1.67) | 0.356 |
SMC | 45 | 317.2 | 141.9 | 0.62 (0.41, 0.92) | 0.019 | 0.62 (0.41, 0.93) | 0.020 |
Received five rounds | |||||||
AL only | 41 | 137.6 | 298.0 | [reference] | – | [reference] | – |
DP | 54 | 139.7 | 386.4 | 1.29 (0.82, 2.05) | 0.274 | 1.16 (0.72, 1.87) | 0.540 |
SMC | 19 | 122.6 | 155.0 | 0.52 (0.29, 0.92) | 0.026 | 0.53 (0.29, 0.95) | 0.033 |
Post‐SMC period | |||||||
All children | |||||||
AL only | 31 | 309.6 | 100.1 | [reference] | – | [reference] | – |
DP | 52 | 305.2 | 170.4 | 1.70 (1.01, 2.86) | 0.045 | 1.34 (0.86, 2.10) | 0.199 |
SMC | 52 | 301.4 | 172.5 | 1.73 (1.00, 2.99) | 0.050 | 1.36 (0.86, 2.14) | 0.187 |
Received five rounds | |||||||
AL only | 23 | 152.6 | 150.7 | [reference] | – | [reference] | – |
DP | 37 | 153.0 | 241.8 | 1.61 (0.87, 3.00) | 0.131 | 1.22 (0.75, 1.98) | 0.418 |
SMC | 38 | 128.6 | 295.6 | 1.97 (1.04, 3.73) | 0.038 | 1.44 (0.86, 2.42) | 0.166 |
Whole study period | |||||||
All children | |||||||
AL only | 103 | 623.6 | 165.2 | [reference] | – | [reference] | – |
DP | 142 | 624.1 | 227.5 | 1.37 (1.00, 1.88) | 0.047 | 1.23 (0.92, 1.65) | 0.168 |
SMC | 97 | 618.5 | 156.8 | 0.95 (0.67, 1.33) | 0.755 | 0.88 (0.65, 1.20) | 0.428 |
Received five rounds | |||||||
AL only | 64 | 290.2 | 220.6 | [reference] | – | [reference] | – |
DP | 91 | 292.8 | 310.8 | 1.41 (0.93, 2.14) | 0.108 | 1.20 (0.83, 1.74) | 0.337 |
SMC | 57 | 251.1 | 227.0 | 1.03 (0.65, 1.62) | 0.913 | 0.91 (0.62, 1.35) | 0.644 |
Rate per 1000 person‐years. SMC period: From date of receipt of first SMC or placebo course, until 1 month after the last SMC course. Post‐SMC period: from 1 month after last SMC course until the end of the study.